RxDoctor Payments DataLook up a doctor →

George Joseph, MD

Clinical Cardiac Electrophysiology · Weirton, WVNPI 1699766931

Payments from drug & device makers

$142,313in general payments, 2019–2025

Across 669 payments — averaging $212.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$42K
  • Johnson & Johnson$35K
  • Boehringer Ingelheim$30K
  • Abbott$9K
  • Medtronic$7K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$7K
  • plus $13K from 30 others

What the payments were for

  • Consulting fees$1,4251%
  • Speaking & faculty fees$74,52577%
  • Travel & lodging$8,2089%
  • Food & beverage$11,51212%
  • Education$8441%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few clinical cardiac electrophysiology providers in West Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$276,907
Medicare patients
400
Services billed
1,392

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban243$160,228
XareltoRivaroxaban86$55,640
Dofetilide217$37,441
Metoprolol Succinate266$3,690
Flecainide Acetate132$3,371
Amiodarone Hcl224$2,632
Mexiletine Hcl27$1,580
Diltiazem 24hr Er (Cd)Diltiazem Hcl45$1,329
Clindamycin Hcl160$1,001
SotalolSotalol Hcl43$565
Carvedilol57$492
Potassium Chloride22$400
Doxycycline Hyclate27$165
Valsartan12$158
Metoprolol Tartrate23$106

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$160,228243 claims
Johnson & JohnsonXarelto$34,587$55,64086 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical cardiac electrophysiology providers in West Virginiaon file to place this against a meaningful peer group, so we don't.

Other clinical cardiac electrophysiology in Weirton

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →